- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04123210
Estimating Average Vitamin A Requirements in Indonesian and American Women
October 29, 2019 updated by: University of Wisconsin, Madison
Development of 13C-Retinol Isotope Dilution Techniques
Women of reproductive age had their vitamin A stores estimated by retinol isotope dilution and then were given vitamin A supplements near the US vitamin A RDA or placebo for 42(USA) or 60 (Indonesia) days, after which retinol isotope dilution was repeated and the change in vitamin A stores was determined in each group to estimate how much vitamin A is needed to maintain nutrient balance in these women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bogor, Indonesia
- Pusat Teknologi Terapan Kesehatan dan Epidemiologi Klinik
-
-
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53706
- University of Wisconsin - Madison
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Normal nutritional status (BMI 18.5-25)
Exclusion Criteria:
- Significant clinical illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vitamin A supplement
Subjects receive a vitamin A supplement containing 175 or 525 micrograms of vitamin A as retinyl palmitate daily
|
|
|
Placebo Comparator: Placebo
Subjects receive an oil placebo containing no vitamin A
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total body vitamin A stores (micromoles of vitamin A)
Time Frame: Baseline and after 42 to 60 days
|
Change in total body stores of vitamin A before and after intervention, measured by retinol isotope dilution
|
Baseline and after 42 to 60 days
|
|
Total vitamin A liver reserves (micromoles vitamin A per gram liver)
Time Frame: Baseline and after 42 to 60 days
|
Change in total liver reserves of vitamin A before and after intervention, measured by retinol isotope dilution
|
Baseline and after 42 to 60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Sherry A Tanumihardjo, PhD, University of Wisconsin, Madison
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 17, 2008
Primary Completion (Actual)
May 5, 2009
Study Completion (Actual)
May 5, 2009
Study Registration Dates
First Submitted
October 7, 2019
First Submitted That Met QC Criteria
October 9, 2019
First Posted (Actual)
October 10, 2019
Study Record Updates
Last Update Posted (Actual)
October 31, 2019
Last Update Submitted That Met QC Criteria
October 29, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2007-0324
- A074600 (Other Identifier: UW- Madison)
- AG&LSC/NUTRITIONAL SCI/NUTRITI (Other Identifier: UW, Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin A Deficiency
-
SourseCitruslabsCompletedMood | Energy Supply; Deficiency | B12 Deficiency VitaminUnited States
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitationIron Deficiency (Without Anemia) | B12 Deficiency VitaminUnited Kingdom
-
Boston UniversityCompletedVitamin D Deficiency | Vitamin E Deficiency | Hypovitaminosis AUnited States
-
Kansas State UniversityNational Institute for Medical Research, Tanzania; United States Department... and other collaboratorsCompletedAnemia, Iron-Deficiency | Deficiency, Vitamin A
-
Newcastle UniversityBill and Melinda Gates Foundation; Institute of Nutrition of Central America... and other collaboratorsUnknownVitamin A Deficiency | Vitamin A Toxicity | Hypervitaminosis AGuatemala, United Kingdom
-
Benha UniversityCompletedVitamin A Deficiency in ChildrenEgypt
-
Fatih Sultan Mehmet Training and Research HospitalActive, not recruitingVitamin D Deficiency | Lipedema | B12 Deficiency VitaminTurkey
-
Second Affiliated Hospital of Wenzhou Medical UniversityNingbo No. 1 Hospital; Ningbo No.2 Hospital; The Children's Hospital of Zhejiang... and other collaboratorsRecruitingVitamin A Deficiency | Idiopathic ScoliosisChina
-
Nottingham University Hospitals NHS TrustNorthern Care Alliance NHS Foundation Trust; Barts & The London NHS Trust; University...RecruitingParesthesia | Neurologic Symptoms | B12 Deficiency Vitamin | Nitrous Oxide Abuse | Subacute Combined Cord DegenerationUnited Kingdom
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of